CEA is an acronym for carcinoembryonic antigen. Doctors will test the blood for CEA levels if they suspect cancer or to see if cancer treatment is helping.
CEA = carcinoma embryonic antigen
The CEA test is not a screening test for cancer. It is not useful for detecting the presence of cancer. Many cancers do not produce an increased CEA level.
For example, only a small percentage of patients with colorectal cancers and rising CEA levels will benefit from another surgical exploration.
It is sometimes referred to as a "flare response." Recognition that a rise in CEA may be temporary and due to therapy is significant.
Unfortunately, this does not always mean the recurrent cancer can be cured.
Cultured Epithelial Autograft
Some noncancerous diseases, such as hepatitis, inflammatory bowel disease, pancreatitis, and obstructive pulmonary disease, may cause an elevated CEA level.
CEA levels may be one of the criteria for determining whether the patient will benefit from more expensive studies, such as CT scan or MRI.
The CEA-2006 compliance is a volunteer based program initiated by the CEA to adopt an industry standard for consumer electronics specifically related to in-vehicle electronics and more specifically to in-vehicle audio amplifiers. Speakers with the CEA-2006 logo will have specifications tested by the CEA standards and these ratings will be compatible for a comparison with CEA-2006 compliant amplifiers. It essentially ensures that your speakers can do and handle what they say they can in terms of the listed specifications.
In general, a higher CEA level predicts a more severe disease, one that is less likely to be curable.
CEA Cesta was created in 1965.
CEA Technologies's population is 260.